Literature DB >> 14635077

Microscopic analysis of chromium accumulation in the bronchi and lung of chromate workers.

Kazuya Kondo1, Yuji Takahashi, Sumiyo Ishikawa, Hiroshi Uchihara, Yukiko Hirose, Kiyoshi Yoshizawa, Masaru Tsuyuguchi, Hiromitsu Takizawa, Takanori Miyoshi, Shoji Sakiyama, Yasumasa Monden.   

Abstract

BACKGROUND: It is known that chromium is an inhaled carcinogen and an important risk factor in the development of lung carcinoma.
METHODS: The authors used a microscopic X-ray fluorescence analyzer with transmitted X-ray mapping imaging (Horiba, Kyoto, Japan) to measure the accumulation of chromium in 10 resected lung tissue specimens and 90 biopsy specimens from chromate workers.
RESULTS: The maximum chromium accumulation (mean +/- standard deviation) in 10 resected lung tissue specimens was 197 +/- 238 counts per second (cps)/mili ampere (mA) (range, 4-649 cps/mA). Chromium accumulation was scattered in six tissue specimens and diffuse in one specimen. Chromium accumulation in the proximal bronchi was less than in the bronchioles or subpleural regions of the lung. Chromium accumulation was detectable in 63 (70%) of 90 biopsy specimens, and the mean accumulation was 6.5 +/- 9.2 cps/mA (range, 0-46.5 cps/mA). Chromium detected in bronchial tissue specimens was deposited in the bronchial stroma but not in the epithelium. The maximum chromium accumulations in dysplasic (n = 3), squamous metaplastic (n = 10), and normal bronchial epithelia (n = 9) in chromate workers and in normal bronchial epithelia (n = 3) in non-chromate workers were 20.2 +/- 5.4, 18.3 +/- 12.2, 13.2 +/- 13.4, and 3.0 +/- 1.8 cps/mA, respectively. The amount of chromium accumulation significantly increased according to the progression of malignant change of the bronchial epithelium (P = 0.003).
CONCLUSIONS: Previous studies found that lung carcinoma with chromate exposure exhibited a variety of genetic abnormalities. Considering genetic aberrations and chromium accumulation in these premalignant lesions is useful for elucidating the process of carcinogenesis in chromium-induced lung carcinoma. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635077     DOI: 10.1002/cncr.11818

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Hexavalent Chromium-Induced Chromosome Instability Drives Permanent and Heritable Numerical and Structural Changes and a DNA Repair-Deficient Phenotype.

Authors:  Sandra S Wise; Abou El-Makarim Aboueissa; Julieta Martino; John Pierce Wise
Journal:  Cancer Res       Date:  2018-06-07       Impact factor: 12.701

2.  Determination of hexavalent chromium in exhaled breath condensate and environmental air among chrome plating workers.

Authors:  Matteo Goldoni; Andrea Caglieri; Diana Poli; Maria Vittoria Vettori; Massimo Corradi; Pietro Apostoli; Antonio Mutti
Journal:  Anal Chim Acta       Date:  2006-03-15       Impact factor: 6.558

Review 3.  Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium.

Authors:  Konstantin Salnikow; Anatoly Zhitkovich
Journal:  Chem Res Toxicol       Date:  2007-10-30       Impact factor: 3.739

4.  The effect of PM10 on human lung fibroblasts.

Authors:  Df Alley; S Langley-Turnbaugh; Nr Gordon; Jp Wise; G Van Epps; A Jalbert
Journal:  Toxicol Ind Health       Date:  2009-03       Impact factor: 2.273

5.  Chromium in exhaled breath condensate and pulmonary tissue of non-small cell lung cancer patients.

Authors:  Matteo Goldoni; Andrea Caglieri; Massimo Corradi; Diana Poli; Michele Rusca; Paolo Carbognani; Antonio Mutti
Journal:  Int Arch Occup Environ Health       Date:  2007-08-28       Impact factor: 3.015

Review 6.  Impact of Carcinogenic Chromium on the Cellular Response to Proteotoxic Stress.

Authors:  Leonardo M R Ferreira; Teresa Cunha-Oliveira; Margarida C Sobral; Patrícia L Abreu; Maria Carmen Alpoim; Ana M Urbano
Journal:  Int J Mol Sci       Date:  2019-10-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.